Sylvie Ryckebusch
Corporate Officer/Principal chez BIOINVENT INTERNATIONAL AB
Postes actifs de Sylvie Ryckebusch
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | 09/06/2022 | - |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Sylvie Ryckebusch
Formation de Sylvie Ryckebusch
| California Institute of Technology | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| France | 2 |
| Suède | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
- Bourse
- Insiders
- Sylvie Ryckebusch
- Expérience
